CT for the Nuclear Medicine Reader

Quick Answer

The CT acquired with most PET/CT and SPECT/CT is a low-dose, non-contrast study with two jobs: attenuation correction and anatomic localization of tracer findings. It is deliberately not a full diagnostic CT — lower dose and no contrast mean lower signal-to-noise and no vascular/parenchymal enhancement. Yet the reader is still responsible for the findings visible on it, so the nuclear medicine physician must be able to read a non-contrast, low-dose CT competently: recognize normal anatomy, judge whether tracer uptake has a benign or worrying CT substrate, and catch the incidental findings that must be reported. This chapter teaches that bounded skill — CT as it serves nuclear medicine, not diagnostic radiology in full.

Two kinds of CT on a hybrid scanner

The CT on a hybrid study is usually low-dose and non-contrast, serving attenuation correction and localization — not diagnosis. A separate full diagnostic CT (higher dose, IV ± oral contrast, thin slices, breath-hold) answers questions the correction/localization CT cannot. Know which one you are looking at: a contrast-enhanced, diagnostic-quality CT changes both what you can say and how it affects attenuation correction (dense contrast can cause overcorrection artifacts).

The reader's responsibility

You are accountable for what is visible on the CT you sign, even a low-dose one — a missed lung nodule, aortic aneurysm, or suspicious mass on the localization CT is still a missed finding. The standard of care is to review the CT systematically, correlate it with the tracer data, and report actionable incidentals. This does not make you a diagnostic radiologist, and a limited non-contrast CT often warrants "recommend dedicated diagnostic CT/MRI for further characterization" rather than a definitive call.

The two numbers that make CT readable: density and windows

CT voxels are measured in Hounsfield units (HU) on a fixed scale — water = 0, air ≈ −1000, fat ≈ −50 to −100, soft tissue ≈ +30 to +60, acute blood ≈ +50 to +80, calcium/bone ≈ +150 to +1000+, metal > +1000. Because that range is huge, you interpret through windows (window level/width): a lung window to see parenchyma and nodules, a soft-tissue window for organs and nodes, and a bone window for cortex and sclerotic/lytic lesions. Reading a scan on the wrong window hides findings — every non-contrast CT read starts with cycling windows.

HU are quantitative and diagnostically useful even without contrast: fat density (< −20 HU) identifies a benign adrenal adenoma, an angiomyolipoma, or a lipoma; fluid density (0–20 HU) suggests a simple cyst; calcium in a lung nodule or lymph node points to a benign/granulomatous or treated process; fat in a node is a benign fatty hilum. Low-dose noise widens the error bars on a single HU measurement, so use HU as a strong clue rather than an absolute, and defer to dedicated CT when a precise threshold (e.g. the 10-HU adrenal-adenoma cutoff) is decision-critical.

Scope — the two buckets, and the line

This chapter is deliberately bounded to CT-as-it-serves-nuclear-medicine, not diagnostic radiology in full — no one expects a nuclear physician to catch a rare diagnosis on a low-dose scan. Everything here serves two buckets: the CT findings urgent enough that you must report them (a safety-net, up to and including direct communication), and the CT findings you should know and see to sharpen your own read (correlating uptake, characterizing substrate, reporting accurately). Where those buckets end and the radiologist's comprehensive diagnostic read begins is drawn explicitly on The Nuclear Medicine–Radiologist Line on CT.

The companion pages follow those buckets: The Nuclear Medicine–Radiologist Line sets the scope; Reading the Low-Dose Non-Contrast CT and Normal Cross-Sectional CT Anatomy build the systematic read; Urgent & Actionable CT Findings to Report is the safety-net bucket; and Correlating Tracer Uptake with CT is the sharpen-your-read bucket. Hybrid-imaging artifacts (misregistration, metal/contrast overcorrection) and FDG-avid incidental findings are covered on their dedicated pages and cross-linked throughout.

High-Yield Pearls

• The hybrid CT is usually low-dose, non-contrast: attenuation correction + localization, not diagnosis.
• You are responsible for visible CT findings on the study you sign — read it systematically and report actionable incidentals.
• Start every CT read by cycling windows (lung / soft-tissue / bone); use HU (fat, fluid, calcium, soft tissue) as benign-vs-worry clues.
• When the low-dose non-contrast CT is limited, recommend dedicated diagnostic CT/MRI rather than over-calling.

Common Pitfalls

• Treating the localization CT as diagnostic — or missing that a contrast-enhanced CT is present (affecting attenuation correction).
• Reading only on soft-tissue window and missing lung nodules or bone lesions.
• Over-relying on a single HU value from a noisy low-dose scan.

Related Pages

• Hybrid imaging & reconstruction: SPECT/PET hybrid imaging; artifacts: Attenuation & misregistration artifacts; incidental findings: Incidental findings on PET/CT.
• Companion pages: Reading the low-dose non-contrast CT, Correlating tracer uptake with CT.

Self-Check

Key References

• SNMMI/EANM practice guidance on PET/CT and SPECT/CT acquisition (low-dose CT for attenuation correction and localization).
• ACR–SNMMI guidance on the interpreting physician's responsibility for findings on the CT component of hybrid studies.